Correlations Between Gene Expression and Mercury Levels in Blood of Boys With and Without Autism
- First Online:
- Cite this article as:
- Stamova, B., Green, P.G., Tian, Y. et al. Neurotox Res (2011) 19: 31. doi:10.1007/s12640-009-9137-7
Gene expression in blood was correlated with mercury levels in blood of 2- to 5-year-old boys with autism (AU) compared to age-matched typically developing (TD) control boys. This was done to address the possibility that the two groups might metabolize toxicants, such as mercury, differently. RNA was isolated from blood and gene expression assessed on whole genome Affymetrix Human U133 expression microarrays. Mercury levels were measured using an inductively coupled plasma mass spectrometer. Analysis of covariance (ANCOVA) was performed and partial correlations between gene expression and mercury levels were calculated, after correcting for age and batch effects. To reduce false positives, only genes shared by the ANCOVA models were analyzed. Of the 26 genes that correlated with mercury levels in both AU and TD boys, 11 were significantly different between the groups (P(Diagnosis*Mercury) ≤ 0.05). The expression of a large number of genes (n = 316) correlated with mercury levels in TD but not in AU boys (P ≤ 0.05), the most represented biological functions being cell death and cell morphology. Expression of 189 genes correlated with mercury levels in AU but not in TD boys (P ≤ 0.05), the most represented biological functions being cell morphology, amino acid metabolism, and antigen presentation. These data and those in our companion study on correlation of gene expression and lead levels show that AU and TD children display different correlations between transcript levels and low levels of mercury and lead. These findings might suggest different genetic transcriptional programs associated with mercury in AU compared to TD children.
c-abl oncogene 1, receptor tyrosine kinase
Aldehyde dehydrogenase 3 family, member B1
Amyotrophic lateral sclerosis 2 (juvenile)
Adaptor-related protein complex 2, alpha 2 subunit
BCL2-antagonist of cell death
BCL2-like 11 (apoptosis facilitator)
Brain-derived neurotrophic factor
Serine/threonine receptor kinase
V-raf murine sarcoma viral oncogene homolog B1
Cell adhesion molecule 1
CDKN2A interacting protein N terminal like
Coiled-coil-helix-coiled-coil-helix domain containing 4
Chromosome X open reading frame 34
Elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 1
Fasciculation and elongation protein zeta 2 (zygin II)
Filamin B, beta (actin binding protein 278)
Glutamate-cysteine ligase, modifier subunit
G Protein-coupled receptors
Major histocompatibility complex, class II, DQ alpha 1
major histocompatibility complex, class II, DQ beta 1
Keratin 1 (epidermolytic hyperkeratosis)
Leishmanolysin-like (metallopeptidase M8 family)
Hypothetical protein LOC100129026
Mitogen-activated protein kinases; serine/threonine receptor kinases
mutS homolog 6 (E. coli)
Mucin 1, cell surface associated
MYB binding protein (P160) 1a
Non-SMC condensin II complex, subunit D3
Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4
nth endonuclease III-like 1 (E. coli)
Neurotrophic tyrosine kinase, receptor, type 3
Peroxidasin homolog (Drosophila)
Ribosomal protein S9
Scavenger receptor class B, member 1
Secreted frizzled-related protein 1
Solute carrier family 25 (mitochondrial carrier: glutamate), member 22
Solute carrier family 7 (cationic amino acid transporter, y+ system), member 8
SMAD family member 2
Somatostatin receptor 3
SUB1 homolog (S. cerevisiae)
T-cell factor; transcription factor
Thioredoxin domain containing 17
Vacuolar protein sorting 25 homolog (S. cerevisiae)
Zinc finger and BTB domain containing 16
Zinc finger, MYM-type 6
Autism (AU) is a neurodevelopmental disorder characterized by impaired social interactions and impaired verbal and nonverbal communication as well as restricted, stereotyped patterns of behavior and interests. The etiology(ies) of autism remains elusive. The interactions of multiple genetic, environmental, and epigenetic factors are postulated to be involved (Ashwood et al. 2006; Hertz-Picciotto et al. 2006; London 2000). Exposures to heavy metals have received much attention because of their developmental neurotoxicity (WHO 1990, 1991; Tchounwou et al. 2003; Clarkson and Magos 2006). Mercury is a toxic and hazardous heavy metal that is ubiquitous in the environment, being found in fish, thermometers, dental amalgams, and in the atmosphere and affects multiple organ systems (WHO 1990, 1991; Tchounwou et al. 2003; Clarkson and Magos 2006; Counter and Buchanan 2004; Zahir et al. 2005). In animals, mercury binds to the endogenous tripeptide glutathione (GSH), and the resulting mercury–glutathione complex is metabolized by the ectoproteins gamma-glutamyl transpeptidase (GGT) and dipeptidase (Rice 2008; Newland et al. 2008; Guzzi and La Porta 2008). Mercury is then eliminated as GSH conjugates, GSH being produced by glutamyl-cysteine ligase (GCL) and conjugation by glutathione S-transferases (GST). The high affinity of mercury for sulfhydryl, and to a lesser degree hydroxyl, carboxyl, and phosphoryl groups of structural and functional proteins, is believed to be the biochemical basis for its harmful effects on biological systems (Clarkson and Magos 2006).
The element mercury exists in three species: elemental mercury (Hgo), inorganic mercury compounds (primarily mercuric chloride), and organic mercury (primarily methylmercury). Exposure to each mercury species can cause general as well as specific toxic effects in children and adults (Clarkson and Magos 2006; Counter and Buchanan 2004). For example, methylmercury derived mostly from fish consumption passes through the blood–brain barrier as an l-cysteine complex via the l-amino acid transporter (Clarkson and Magos 2006; Mokrzan et al. 1995). The mechanisms by which inorganic mercury damages human brain, however, are poorly understood. The different mercury species have different absorption, distribution, metabolism, excretion, and toxicity (Guzzi and La Porta 2008; Ercal et al. 2001; Quig 1998). In addition, the effect of a toxicant can be influenced by another substance, so-called “mixture toxicity” (Rice 2008; Newland et al. 2008; McCarty and Borgert 2006a, b).
The development of whole genome microarrays has made it possible to characterize how the entire transcriptome of cells or organisms responds to changes in external or internal environments. Measurements of gene expression (RNA) levels provide a “transcriptional signature” of an individual’s genetic, physiological, and environmental status. The relationship between levels of xenobiotics and transcriptional signatures measured in blood can be used to provide mechanistic information about toxic exposures (Yoon et al. 2008).
The objective of the current study was to analyze the entire transcriptome in similar aged typically developing (TD) and AU boys to identify those genes whose expression level in blood correlated with relatively low total mercury (Hg) levels in blood. Moreover, the correlations of RNA levels with Hg levels might differ in AU compared to TD boys. Lastly, we postulated that differences in RNA expression signatures for AU compared to TD boys would occur not only for Hg but would also be different for other xenobiotics including lead (Tian et al. 2009, accompanying paper). This study begins to address these hypotheses.
Materials and Methods
Subjects were participants in the CHARGE study (Hertz-Picciotto et al. 2006). These children were assessed at the UC Davis Medical Investigations of Neurodevelopmental Disorders (M.I.N.D.) Institute. Each child was evaluated using standardized clinical assessments. AU cases were assessed using the Autism Diagnostic Interview–Revised (ADI-R) (Le Couteur et al. 2003; Lord et al. 1994, 1997) and the Autism Diagnostic Observation Schedules (ADOS) (Lord et al. 2000, 2003). For this study of gene expression versus Hg levels, we analyzed boys with AU (n = 33, mean age 45.3 with a range of 31–60 months) and age-matched TD control boys (n = 51, mean age 43.3 with a range of 28–57 months). Only subjects for whom the Affymetrix expression data was generated in 2007–2008 were analyzed because Affymetrix arrays processed prior to those times were done using a different protocol which resulted in significant technical variation. Only boys were analyzed in our study because there were few girls who had both Affymetrix expression data and blood Hg data. The subjects used in our companion study on correlation between gene expression and blood lead levels are different from the ones used in this study. Parents provided informed consent for all subjects (Tian et al. 2009). The study was approved by the Institutional Review Board at University of California Davis Medical Center and was conducted in accordance with the Declaration of Helsinki.
Total blood Hg was measured on an Agilent 7500i Inductively Coupled Plasma Mass Spectrometer (ICP-MS) (Agilent, Palo Alto, CA) in the UCD Department of Civil and Environmental Engineering. Detailed methods are included in our previous publication (Hertz-Picciotto et al. 2009). Blood Hg concentrations were log2-transformed due to the skewed distribution over a wide range of values (Fig. 2). The normality of the distributions was assessed by performing the Kolmogorov–Smirnov test in Partek Genomics Suite 6.4. The detection limit for Hg was 0.02 μg/l (Hertz-Picciotto et al. 2009), with the (slightly) lower detection limit of 0.01 μg/l (limit of barely detected). Log2-transformation of the Hg levels was performed to produce a more linear distribution of the values and to match the log2-transformation of gene expression (see below). For log2-transformation of the Hg data, Hg levels below detection levels were assigned a value of 0.009 μg/l. The value of 0.009 was selected to be slightly lower than the lower limit of Hg detection of 0.01 μg/l in order to not create “outlying” values, which can artificially influence the correlation coefficient.
RNA Isolation and Affymetrix Array Hybridizations
Whole blood was collected and total RNA was isolated using PAXgene tubes and kits (Qiagen, Valencia, CA). RNA concentration and purity were checked using a Nanodrop ND-1000 spectrophotometer, and integrity was checked using the Agilent 2100 Bioanalyzer (260/280>2.0; 28S/18S>1.5; RIN>8).
Human whole genome U133 Plus 2.0 GeneChip microarrays (Affymetrix; Santa Clara, CA), surveying over 54,000 probe sets, were used. The 54,000 probe sets represent over 38,500 potential human genes (Affymetrix Manual). The standard Affymetrix protocol was followed for the sample labeling, hybridization, and image scanning.
Analysis of Affymetrix Expression Array Data
Raw gene expression values from Affymetrix.cel files were imported into Partek Genomics Suit, version 6.4, release 6.09.0422 (Partek Inc., St. Louis, MI). Probe summarization and probe set normalization were performed using the GC-RMA algorithm (Wu and Irizarry 2004), including GC-RMA background correction, Quantile Normalization, log2-transformation, and Median Polish probe set summarization.
Analysis of Covariance
Model 1: TD Boys Only
Log2(Gene Expression) is a function of the following factors: Log2Hg (continuous), Age (continuous), and Batch (categorical). Genes with a P(Log2(Hg)) ≤ 0.05 in this model would be associated with the left circle in Fig. 1.
Model 2: AU Boys Only
Log2(Gene Expression) is a function of the following factors: Log2Hg (continuous), Age (continuous), and Batch (categorical). Genes with a P(Log2(Hg)) ≤ 0.05 in this model would be associated with the right circle in Fig. 1.
Model 3: AU and TD Boys Combined
Log2(Gene Expression) is a function of the following factors: Log2Hg (continuous), Age (continuous), Batch (categorical), Diagnosis (binary categorical), and interaction Diagnosis*Log2Hg.
Genes with a P(Diagnosis*Log2Hg) ≤ 0.05 would be associated with the top circle in Fig. 1.
Gene list A represents genes whose expression correlates with Log2Hg levels in each of the TD and AU models separately (P(Log2Hg) ≤ 0.05), with no significant differences in the correlations between the two groups in the combined AU + TD model (P(Diagnosis*Log2Hg) > 0.05).
Gene list B represents genes whose expression correlates with Log2Hg levels in each of the TD and AU models separately (P(Log2Hg) ≤ 0.05), and had significant differences in the correlations between the two groups in the combined AU + TD model (P(Diagnosis*Log2Hg) ≤ 0.05).
Gene list C represents genes whose expression correlates with Log2Hg levels in the TD model (P(Log2Hg) ≤ 0.05) but not in the AU model (P(Log2Hg) > 0.05), and which had significant differences in the correlations between the two groups in the combined AU + TD model (P(Diagnosis*Log2Hg) ≤ 0.05).
Gene list D represents genes whose expression correlates with Log2Hg levels in the AU model (P(Log2Hg) ≤ 0.05) but not in the TD model (P(Log2Hg) > 0.05), and which had significant differences in the correlations between the two groups in the combined AU + TD model (P(Diagnosis*Log2Hg) ≤ 0.05).
Assessment of Possible Biological Significance of Identified Genes
Gene ontology annotation was obtained from the Affymetrix NetAffix database (www.affymetrix.com). Pathway analysis was performed using Ingenuity Pathways Analysis (IPA) (Ingenuity Systems®, www.ingenuity.com). A dataset containing gene identifiers (called focus molecules) from each of the lists (A, B, C, or D) was uploaded into the program. Each identifier was mapped to its corresponding gene object and overlaid onto a global molecular network developed from information contained in the Ingenuity knowledge base. The Bio Functional Analysis identified the biological functions and/or diseases that were most significant to the dataset. Canonical Pathway Analysis identified the pathways from the IPA library of canonical pathways that were most significant to the dataset. The significance of the association between the dataset and canonical pathways was assessed by calculating the ratio of the number of genes from the dataset that map to the pathway divided by the total number of molecules that exist in the canonical pathway. A Right-tailed Fischer’s Exact Test was then used to calculate a P-value determining the probability that each biological function and/or disease assigned to that dataset is due to chance alone. A P < 0.05 was considered to be statistically significant for over-representation of the molecules in a given process. Thus, over-represented functional or pathway processes are processes which have more focus molecules than expected by chance. It should be noted that for lists A and B (Figs. 1, 3), due to the small number of genes, pathway over-representation is not possible. In this case, IPA was used to map the genes into their corresponding pathways and biofunctions. Genomatix software (http://www.genomatix.com) was utilized to identify over-represented transcription factor binding sites in each of the four gene lists (A–D, Fig. 1).
Chromosome and cytoband enrichment for each of the gene lists (lists A, B, C, and D) as well as functional annotation of the probe sets in the enriched chromosomes was performed in DAVID (http://david.abcc.ncifcrf.gov/tools.jsp). A modified Fisher Exact P-value (the threshold of EASE score) for gene enrichment analysis was used. We considered the default P ≤ 0.1 to be considered strongly enriched in the annotation categories. A default value of 2 for the threshold of the minimum gene counts belonging to an annotation term was adopted. Visual representation of the statistically enriched chromosomes was done using Partek and was presented in Supplementary figures 1–3.
Genes Whose Expression Correlated with Hg Levels in TD and AU Boys
Genes Whose Expression Levels Correlated with Hg Levels and Exhibited a Similar Trend in Both TD and AU
Top biological functions for the gene lists A, B, C, D
Genes (+ [in bold]; − [in italics])
List A: Common genes
MSH6, CADM1, SSTR3
Cell-to-cell signaling interaction
Cell-mediated immune response—cytokine secretion
Response to oxidative stress
Transcription regulation, DNA dependent
List B: Contrasting genes
Cellular assembly and organization
Synapse density and axon extension
Chromosome segregation and alignment
Cytoskeleton anchoring and biogenesis
Vestibular ganglion neuron degeneration
Actin filament disorganization
Small molecule biochemistry
Apoptosis of neurons and granular cells, sensory neuron survival
List C: Genes correlating with mercury (TD only)
Apoptosis (A.) of brain cells
NFATC4, BAD, BDNF, GCLM
Axon recovery and regeneration
Apoptosis of corticospinal neurons
Killing of neurons
Killing of normal cells
BAD, BCL2L11, BDNF
Cell death of interneurons
Normal cell death delay
Brain cell death
NFATC4, BAD, BCL2L11, BDNF, GCLM
Brain cell loss
Memory B cell and neuron survival
BRAF, BCL2L11, BDNF
Pro-B lymphocyte survival
Apoptosis of pre-T lymphocytes
Red blood cell morphology
Memory B cell division delay
Mitochondria transmembrane potential
ABL1, ZBTB16, GNLY, AP2A2, BCL2L11, MUC1, TCF3
ABL1, GNLY, BCL2L11
Axon sprouting and projection
NFATC4, BDNF, PMCH
ABL1, ARID1A, BHLHB2, BMPR2, FAM130A1, FOXK1, HOXB4, MAFF, NFATC4, SMAD2, ZBTB16, ZBTB38, AP2A2, BAD, BDNF, CEBPD, FERD3L, FOXI1, GARNL1, HIF3A, KLF2, KLF12, LANCL2, MTRF1, RNF141, SFRP1, STUB1, SUB1, TCF3, TRIB3, ZNF10, ZNF174, ZNF254
ARID1A, BHLHB2, BMPR2, NFATC4, SMAD2, ZBTB38, BAD, BDNF, CEBPD, HIF3A, TCF3, RGNEF
BHLHB2, SSBP1, CEBPD, TCF3
Co-Activation of TCF binding site
ABL1, ARID1A, SH3BP2, SMAD2, ZBTB16, BDNF, CEBPD, HIF3A, KLF2, PRKDC, STUB1, SUB1, TCF3, ZNF10
List D: Genes correlating with mercury (AU only)
Vacuolation of embryonic, epithelial and kidney cell lines
Length of actin stress fibers
Morphology of intercalated discs and myofibrils
Morphology of focal adhesions
Elongation of gonadal cell lines
Amino acid metabolism
Glutamine utilization, glutathione and l-cysteine metabolism quantity
Transport of l-amino acid
Infiltration of multinucleated giant cells
Antibacterial response of organism
SLC11A1, NLRP1, NOD1
Antigen processing and presentation of peptide or polysaccharide antigen via MHC class II
Chromosome enrichment for the probe sets from the four list (lists A, B, C, and D)
Probe sets in list, count
Probe set, count
% probe sets/chromosome
19, 7, 13
30, 23, 10
9.3, 7.2, 3.1
0.02, 0.03, 0.08
Genes Whose Expression Significantly Correlated with Hg Levels but have Opposite Trends in TD and AU Boys
Genes Whose Expression Correlated with Hg Levels in TD but not in AU Boys
Genes Whose Expression Correlated with Hg Levels in AU but not in TD Boys
Analysis of All Genes Correlating with Hg Levels in AU and/or TD
Comparison of Genes Correlating with Hg Levels Only in TD (List C) and Only in AU (List D)
Though some of the genes and pathways are similar, the major finding of the study is that almost all of the genes that correlate with circulating Hg levels in AU boys are different from TD boys, and almost all of the genes that correlate with circulating Hg levels in TD boys are different from AU boys. These transcriptional differences were observed even though the Hg levels were low and not significantly different between the groups in our study. Since the data reported are only correlations, no conclusions can be drawn as to whether Hg plays any role in the pathogenesis of autism based upon the current results. Given the low Hg levels and the fact that this is a cross-sectional study, no cause and effect relationship should be drawn from the current data. Though the data can be interpreted in several ways, we suggest that the different transcriptional programs associated with Hg in AU compared to TD subjects may be related to the genetic differences in the two groups of children.
Common Genes (List A and List B) and Common Pathways
The major finding of this study is that very few genes that correlated with Hg levels in AU subjects also correlated with Hg levels in TD subjects. There were only 15 genes that correlated with Hg levels in both the TD and AU groups—and that were not significantly different between the two groups. These genes were involved in apoptosis, the immune response, and response to oxidative stress. Moreover, there were only 11 genes whose expression correlated inversely with Hg levels in AU compared to TD subjects—that is genes correlating with Hg levels in both groups but in opposite directions. These genes were involved in pathways contributing to neuronal development and neuronal survival and cell death. Notably, one gene (FLNB, filamin B, beta (actin binding protein 278)), which was positively correlated with Hg levels in TD and negatively correlated in AU subjects, is involved in anchoring and biogenesis of cytoskeleton and organization of actin filaments (Xu et al. 1998; Tu et al. 2003; Leedman et al. 1993). A number of studies show that most heavy metals, including zinc, arsenic, mercury, and cadmium, can disrupt actin and microtubules in intact cells (Templeton 2000).
The analysis of all genes correlating with Hg levels in all AU and TD subjects showed a number of common networks. Figure 8 is a good example where different genes from the different groups are regulated within the same network. This could suggest that similar functions might be accomplished with different genes in AU compared to TD, and that homeostasis is maintained in spite of the genetic differences of AU and TD subjects.
Genes Correlating with Hg Levels in TD but not in AU Boys (List C)
Thus, most of the genes whose expression correlated with Hg levels in the TD group were different from those whose expression correlated with Hg levels in the AU group. For the TD subjects, the top biological function for the genes that correlated with Hg levels was cell death. Some of these genes were involved in apoptosis of neurons (NFATC4, BAD, BDNF) (Graef et al. 2003; Ottilie et al. 1997; Hoey et al. 1995; Botta et al. 2004; Kerschensteiner et al. 1999; Mamounas et al. 1995), survival of neurons, recovering and regeneration of axons (BDNF, RTN4) (Kerschensteiner et al. 1999; GrandPre et al. 2000), apoptosis of pre-T lymphocytes (BCL2L11) (Bouillet et al. 1999), survival of pro-B lymphocytes, and survival of memory B cells (BRAF, BCL2L11, BDNF, TCF3) (Oliver et al. 2004; Fischer et al. 2007). It is interesting that most of these correlations are negative. Chronic exposure to low concentrations of heavy metals, including mercury, causes immune dysfunction related in large part to apoptosis of leukocytes (Pollard and Hultman 1997; Zelikoff and Gardner 1996; Laiosa et al. 2007; Madureira et al. 2007; Ziemba et al. 2005; Mondal et al. 2005; McCabe et al. 2003, 2005; Cunha et al. 2004; Sarmento et al. 2004; Kuo and Lin-Shiau 2004; Colombo et al. 2004; Field et al. 2003). Both inorganic and organic mercurials cause human T-cell apoptosis with mitochondria being the target organelle for the induction of cell death (Shenker et al. 1999). In addition, microarray analysis of Hg-induced changes in gene expression in human liver carcinoma (HepG2) cells revealed genes involved in apoptosis and metabolic regulation with significant effects on genes involved in immune system pathways (Ayensu and Tchounwou 2006). However, the levels of Hg applied to the cells were much higher than the Hg levels of the subjects in our study.
The second major biological function for genes that correlated with Hg levels in TD subjects was cell morphology and cell death. Mercury-induced cell death can be apoptotic or nonapoptotic. The nonapoptotic cell death produced by mercury is associated with a specific cellular morphology (Pollard et al. 1997, 2000). Mercury-induced apoptosis results from dys-regulated signal transduction that leads to inactivation of enzymes, generation of free radicals and peroxides, protein conformation changes, and inhibition of transport processes which disrupt cell membrane permeability (Tchounwou et al. 2003; Clarkson and Magos 2006; Counter and Buchanan 2004; Zahir et al. 2005). Genes associated with transmembrane potential and permeabilization of mitochondria correlated with Hg levels in TD subjects in our study. Mercury-induced membrane changes of mitochondria associated with glutathione imbalance and antioxidant defenses have been reported in TD versus AU transformed lymphoblastoid lines (James et al. 2009). Mercury increases mitochondrial permeability, which is characterized both by a decline in transmembrane potential and intracellular pH, as well as the generation of reactive oxygen species and a decline in T-cell GSH content (Shenker et al. 2000). In our study, Granulysin (GNLY) showed a positive correlation with Hg levels in the TD group. GNLY is a cytolytic and pro-inflammatory molecule, which contributes to mitochondrial damage (Krensky and Clayberger 2009). B-cell lymphoma 2-like protein 11 (apoptosis facilitator) (BCL2L11) showed a negative correlation with Hg in the TD group in our study. BCL2L11 (also known as BIM) is a BH3-only protein from the Bcl-2 family (Youle and Strasser 2008), whose family members are the main regulators of programmed cell death via the mitochondrial (intrinsic) apoptotic pathway. Interactions between pro- and anti-apoptotic proteins of the Bcl-2 family decide the fate of cells in response to stress signals. BCL2L11 is essential for hematopoietic homeostasis and thymocyte negative selection, and suppresses autoimmunity (Youle and Strasser 2008).
Some of the cell morphology genes that correlated with Hg levels in TD subjects also have functions within the central nervous system. These included genes that affect neuronal survival (ABL1 (+), BDNF (−)), sprouting and projection of axons (BDNF (−), RTN4 (−)), plasticity of the synapse (BDNF (−), NFATC4 (+), PMCH (−)), and remodeling of axons (SFRP1 (−)) (Kerschensteiner et al. 1999; GrandPre et al. 2000; Gascon et al. 2007; DeFreitas et al. 2001; Mamounas et al. 2000; Fournier et al. 2001; Seil 1998; Groth and Mermelstein 2003; Krylova et al. 2002). It is possible that mercury affects these genes in the brain as well as the blood, and this might relate to neurotoxicity observed following exposure to much higher levels of mercury (Rice 2008; Guzzi and La Porta 2008).
We observed a negative correlation between GCLM and Hg levels in TD, but no correlation in AU. GCLM is a member of the glutamate-cysteine ligase complex, which is the first rate-limiting enzyme of the glutathione synthesis, and is the major route of mercury detoxification.
James et al. (2009) observed a reduced glutathione reserve capacity in both cytosol and mitochondria in lymphoblastoid cells derived from children with autism when compared to children without autism. Glutathione reserve capacity is an indicator of systemic redox status that can be used to assess and treat individuals at risk of oxidative stress-related pathology (Jones 2006a, b). In our study, we observed a negative partial correlation between GCLM transcript abundance and Hg levels in the TD group, while there was no significant correlation in the AU group. GCLM is transcriptionally regulated in human HepG2 cells (Lee et al. 2006). We also observed a negative partial correlation between GGT1 transcript abundance and Hg levels in the AU group, while there was no significant correlation in the TD group (see section “Genes Whose Expression Correlates with Hg Levels in AU but not in TD Boys (List D)”). GGT1 is involved in the utilization of l-glutamate, l-cysteine, and glutathione metabolism. It is involved in the generation of l-glutamate, which is a substrate for glutathione synthesis. Thus, if there is negative regulation of this gene, there may be less substrate for the glutathione biosynthesis pathway, which may affect the redox status. Overall, our studies of transcript abundance in blood of AU and TD boys are difficult to relate to the in vitro studies of AU and TD lymphoblastoid cell lines except to say that both approaches show associations between genes in the glutathione pathways and Hg levels.
CDKN2AIPNL and ZMYM6 negatively correlated with Hg levels in this study and both were downregulated with mercury treatment in human liver carcinoma (HepG2) cells (Ayensu and Tchounwou 2006). ALDH3B1, RPS9, SUB1, and VPS25 also were negatively correlated with Hg in TD subjects in this study and were downregulated in Hg-treated yeast (Jin et al. 2008).
Genes whose expression correlated similarly with Hg levels both in TD and AU (List A) and whose expression correlated with Hg levels only in the AU group (List D) have transcription factor (TF) binding sites for SP1 and Kruppel-like factor (KLF)-like TFs, respectively. KLF6, which is an Sp1-like zinc finger transcription factor, is a transactivator of inducible nitric oxide synthase (iNOS) (Warke et al. 2003), which produces NO and modulates inflammatory signals and oxidative stress (Mungrue et al. 2003).
Genes Whose Expression Correlates with Hg Levels in AU but not in TD Boys (List D)
One of the top biological functions in the list of genes that correlated with Hg levels in AU but not TD boys was amino acid metabolism. The genes included gamma-glutamyltransferase (GGT1/2/3; probe 244179_x_at); as well as solute carrier family 25 (mitochondrial carrier: glutamate), member 22 (SLC25A22 (−)), and solute carrier family 7 (cationic amino acid transporter, y+ system), member 8 (SLC7A8 (−)) which are involved in the transport of l-amino acids (Pineda et al. 1999). SLC7A8, which had negative partial correlation with Hg levels in the AU group in our study, was upregulated in mercury-treated yeast cells (Jin et al. 2008).
FAF1 (Fas-associated factor 1) expression was positively correlated with Hg levels in AU but not TD subjects. Fas is a member of the tumor necrosis receptor factor family, which can induce apoptosis when activated by Fas-ligand binding (Chu et al. 1995). Apoptosis induced by Fas plays an important role in the development and function of the immune system (Lowin et al. 1994; Nagata 1994). Genetic studies in mice show that defects in Fas-mediated apoptosis resulted in abnormal development and function in the immune system (Takahashi et al. 1994). FAF-1 also inhibits the NF-κB activation induced by various stimuli, including tumor necrosis factor-α, interleukin-1β, and lipopolysaccharide (Park et al. 2004). NF-κB is a central regulator of genes involved in the immune response, inflammatory response, and apoptosis (Beg and Baltimore 1996; Pahl 1999; Baldwin 1996).
CHCHD4 (negatively correlated with Hg level in AU), ELOVL1, SLC7A8, and Cxorf34 (positively correlated with Hg level in AU) responded to mercury in yeast in the same direction as in our AU subjects. NTHL1 (positively correlated with Hg level in AU) was downregulated in yeast after mercury treatment, whereas MYBBP1A (positively correlated in AU) was up- or downregulated depending on the treatment dose (Jin et al. 2008).
HLA-DQ, an αβ heterodimer of the MHC Class II type which is a cell surface molecule found on antigen presenting cells, presents antigens to T-lymphocytes (Germain and Margulies 1993; Janeway et al. 1997; Kwok and Nepom 1998). The α and β chains are encoded by HLA-DQA1 and HLA-DQB1, respectively, and both the α- and β-chains vary greatly in the population. Different DQ isoforms can bind to and present different antigens to T-cells. Several lines of evidence suggest that mercury toxicity depends on the mercury species, dosage, individuality, and the type of MHC association (Ayensu et al. 2004; Hanley et al. 1997, 2002). Moreover, chronic exposure to low concentrations of heavy metals such as mercury results in immune dysfunction (Ayensu et al. 2004; Hanley et al. 1997, 2002). Immune dysregulation has been observed in autism, and has been postulated to play a role in the development and pathogenesis of autism in some cases (Warren et al. 1996, 1997; Singh and Rivas 2004; Ashwood et al. 2006; Gupta et al. 1996). In this study, we found that HLA-DQA1 was negatively correlated, whereas HLA-DQB1 was positively correlated with Hg levels in AU but not TD subjects. They both were downregulated in response to mercury in human liver carcinoma (HepG2) cells (Ayensu and Tchounwou 2006).
Comparison of Genes Correlating with Hg Levels Only in TD or Only in AU (List C or D)
There is a different association between transcript level and circulating Hg levels in the TD and AU subjects that involves genes from the TGF-β signaling pathway. TGF-β signaling regulates cell growth, cell differentiation, cellular homeostasis, apoptosis, and immune responses. TGF-β binds to and activates the TGF-β receptor, which then activates the SMAD family of transcriptional regulators. SMAD2 and SMAD3 mediate TGF-β and activin signals, while SMAD1, SMAD5, and SMAD8 act downstream of bone morphogenetic proteins (BMPs) (Zhang and Derynck 1999; ten Dijke et al. 2000; Massague and Wotton 2000). SMADs dimerize with SMAD4 and translocate to the nucleus where the complex modulates transcription of target genes. In our study, we found bone morphogenetic protein receptor type 2 (serine/threonine kinase) (BMPR2) and SMAD2 to be positively correlated with Hg levels in TD but not in AU subjects. Notably, Ashwood et al. (2008) observed decreased TGF-β1 plasma levels in children with autism spectrum disorders when compared to typically developing controls.
Hg Levels in AU and TD
Hg levels in children from the CHARGE study with and without autism have been studied in detail (Hertz-Picciotto et al. 2009). The Hg levels in the TD and AU groups were quite similar in this sample to those in the larger CHARGE sample: means of 0.60 μg/l for TDs in both groups, and means of 0.46 and 0.49 μg/l for the AU/ASD children in this subsample and the larger study (Hertz-Picciotto et al. 2009). Thus, the sample of subjects in this study is representative of the CHARGE study as a whole. None of the samples used in this study had Hg levels higher than the EPA reference level of 5.8 μg/l. The median Hg concentration and inter-quartile range were comparable to those of the U.S. population of children ages 1–5 years in 1999–2002 (McDowell et al. 2004). It is notable, therefore, that the gene expression differences described here occurred in the EPA allowable range. This is consistent with previously reported dose-dependent effects of Hg (Tchounwou et al. 2003; Clarkson and Magos 2006; Counter and Buchanan 2004; Zahir et al. 2005) and with a dose-dependent transcriptional response in human liver carcinoma cell lines treated with mercury (Ayensu and Tchounwou 2006). It is important to emphasize that acute intoxication with much higher mercury concentrations or even chronic exposure to much higher Hg concentrations might produce different transcript associations.
Limitations of the Study
Samples collected from children ages 2–5 in this study do not directly address the role of Hg as a possible causal factor for autism which likely begins in utero or shortly after birth. In addition, it is important to emphasize that one cannot infer cause and effect from the data presented in this study. Our data shows that there are associations between transcript levels and circulating Hg levels which are different in the AU compared to the TD group. It is possible that these low levels of Hg cause changes of gene expression in the white blood cells that could affect the function of immune cells that could play a role in the pathogenesis of autism. Alternatively, and perhaps more likely, the altered transcriptomic associations with low levels of Hg in AU may have no functional effect on immune cells, brain, or other organs. Further studies on protein levels of the genes whose expression was associated with mercury levels should be conducted. Protein levels may or may not reflect RNA levels, particularly in stressed cells. Again, correlation does not mean causality and extreme caution should be exercised when interpreting the correlations reported here. In addition, since this is a one-time study, the correlation of an individual gene might not be replicated in future studies due to stochasticity.
The P-values which were used to derive the gene lists indicate statistical but not biological significance. It is unclear what level of correlation of gene expression and Hg levels represents biological significance. Correlation is also affected by “outlying” values. One way of reducing this effect is by log-transforming the data as was done here. Also, the somewhat unequal sample sizes may affect the calculation of the P-values and thus lead to some skewing of the data. The strengths of the correlations were not large for most of the identified genes. Therefore, caution should be exercised regarding the correlation of gene expression with Hg level for a given gene.
No gene reported here passed a multiple comparison correction for statistical significance. We addressed this problem in part by focusing on genes common to at least two of the ANCOVAs. However, the finding that so few genes correlated with Hg levels in both AU and TD subjects implies that multiple comparisons had no impact on the major conclusion of this study: AU and TD children have different associations between transcript level and circulating Hg levels. Increasing multiple comparisons would have made it likely that there would be many transcripts that correlated with Hg and were common to the AU and TD groups.
This study evaluated a single sample of blood where only 5% of the body burden of Hg is found (Burbacher et al. 2005; Stinson et al. 1989). The different Hg species were not measured (Goldman and Shannon 2001; Clarkson 2002). It is likely that different Hg species induce specific genes and affect specific enzymes that mediate Hg species specific toxicity (Clarkson and Magos 2006; Aschner et al. 2006).
The observed correlation between Hg levels and gene expression might be due to other factors that were not included in our ANCOVA models. Different diets of AU compared to TD subjects might affect gene expression. For example, fish is a major source of organic mercury intake and in the larger CHARGE study sample (Hertz-Picciotto et al. 2009) accounted for the differences in mercury levels between subjects. Fish contain n-3 polyunsaturated fatty acids, which are potent regulators of gene expression (Price et al. 2000). It is possible that some of the associations observed in this study are confounded by n-3 polyunsaturated fatty acids levels or other molecules found in fish.
The authors thank the CHARGE study staff for recruitment, assessment, and data collection and the many families who participated. We also thank the UCD genomics core for processing the samples. This study was supported by NIH grant (I P01 ES11269) (1 R01 ES015359), the U.S. Environmental Protection Agency through the Science to ARCHIVE Results (STAR) program (R829388, R833292), a Cure Autism Now (Autism Speaks) grant, a UC Discovery (Industry-University Cooperative Research Program) grant, and an award from the Clinical and Translational Science Center (CTSC) and MIND Institute at UCD. The authors declare they have no competing financial interests.
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.